Advanced Search

Home > Journals > The Quarterly Journal of Nuclear Medicine and Molecular Imaging > Past Issues > The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1)

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUETHE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A Journal on Nuclear Medicine and Molecular Imaging

A Journal on Nuclear Medicine and Molecular Imaging
Affiliated to the Society of Radiopharmaceutical Sciences and to the International Research Group of Immunoscintigraphy
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index (SciSearch), Scopus
Impact Factor 2,413

Frequency: Quarterly

ISSN 1824-4785

Online ISSN 1827-1936

 

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1)

     PREFACE

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):1

The importance of dosimetry in nuclear medicine therapy practice

Bisi G.


DOSIMETRY IN NUCLEAR MEDICINE - PART I 

     FOREWORD

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):2-4

Dosimetry in nuclear medicine therapy

Chiesa C., Lassmann M.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):5-20

Dosimetry in nuclear medicine therapy: what are the specifics in image quantification for dosimetry?

Bardiès M., Buvat I.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):21-43

Quantitative imaging of 124I with PET/ CT in pretherapy lesion dosimetry Effects impairing image quantification and their corrections

Jentzen W., Freudenberg L., Bockisch A.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):44-56

From imaging to dosimetry and biological effects

Konijnenberg M.


     ORIGINAL ARTICLES

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):57-65

Could [18]F-fluorodeoxyglucose PET/CT change the therapeutic management of stage IV thyroid cancer with positive 131I whole body scan?

Piccardo A., Foppiani L., Morbelli S., Bianchi P., Barbera F., Biscaldi E., Altrinetti V., Villavecchia G., Cabria M.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):66-71

Imaging the inflammatory activity of sarcoidosis: sensitivity and inter observer agreement of 67Ga imaging and 18F-FDG PET

Keijsers R. G., Grutters J. C., Thomeer M., Du Bois R. M., Van Buul M. M., Lavalaye J., Van Den Bosch J. M., Verzijlbergen F. J.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):72-80

Prognostic role of the PET parameter maximum standardized uptake value in non small cell lung cancer: analysis in tumour of diameter ≥ and <25 mm

Pelosi E., Billè A., Skanjeti A., Errico L., Arena V., Ardissone F., Borasio P., Mancini M.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):81-90

[18F]FDG-PET/CT monitoring early identifies advan-ced ovarian cancer patients who will benefit from prolonged neo-adjuvant chemotherapy

Martoni A. A., Fanti S., Zamagni C., Rosati M., De Iaco P., D’Errico Grigioni A., Castellucci P., Quercia S., Musto A., Ricci Maccarini L., Lopci E., Bernardi A.


The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):91-102

Introduction of a new semi-quantitative index with predictive implications in patients with painful osseous metastases after 186Re-HEDP therapy

Zafeirakis A., Zissimopoulos A., Baziotis N., Limouris G. S.


     LETTERS TO THE EDITOR

The Quarterly Journal of Nuclear Medicine and Molecular imaging 2011 February;55(1):103-4

Technetium-99m supply shortage. Possible solutions in every day nuclear cardiology practice

Marcassa C., Campini R., Zoccarato O., Calza P.


top of page